Clinical Trial Update: Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating early low-dose corticosteroid therapy for acute respiratory distress syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Respiratory Distress Syndrome

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Acute Respiratory Distress Syndrome, Acute Lung Injury | Phase 2 | Status: COMPLETED